Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
The XIST lncRNA is a sex-specific reservoir of TLR7 ligands in SLE
Jonathan D. Crawford, … , Brendan Antiochos, Erika Darrah
Jonathan D. Crawford, … , Brendan Antiochos, Erika Darrah
Published September 21, 2023
Citation Information: JCI Insight. 2023;8(20):e169344. https://doi.org/10.1172/jci.insight.169344.
View: Text | PDF
Research Article Immunology

The XIST lncRNA is a sex-specific reservoir of TLR7 ligands in SLE

  • Text
  • PDF
Abstract

Systemic lupus erythematosus (SLE) is a systemic autoimmune disease with a dramatic sex bias, affecting 9 times more women than men. Activation of Toll-like receptor 7 (TLR7) by self-RNA is a central pathogenic process leading to aberrant production of type I interferon (IFN) in SLE, but the specific RNA molecules that serve as TLR7 ligands have not been defined. By leveraging gene expression data and the known sequence specificity of TLR7, we identified the female-specific X-inactive specific transcript (XIST) long noncoding RNA as a uniquely rich source of TLR7 ligands in SLE. XIST RNA stimulated IFN-α production by plasmacytoid DCs in a TLR7-dependent manner, and deletion of XIST diminished the ability of whole cellular RNA to activate TLR7. XIST levels were elevated in blood leukocytes from women with SLE compared with controls, correlated positively with disease activity and the IFN signature, and were enriched in extracellular vesicles released from dying cells in vitro. Importantly, XIST was not IFN inducible, suggesting that XIST is a driver, rather than a consequence, of IFN in SLE. Overall, our work elucidated a role for XIST RNA as a female sex–specific danger signal underlying the sex bias in SLE.

Authors

Jonathan D. Crawford, Hong Wang, Daniela Trejo-Zambrano, Raffaello Cimbro, C. Conover Talbot Jr., Mekha A. Thomas, Ashley M. Curran, Alexander A. Girgis, John T. Schroeder, Andrea Fava, Daniel W. Goldman, Michelle Petri, Antony Rosen, Brendan Antiochos, Erika Darrah

×

Figure 4

XIST expression in PBMCs correlates with SLE status and disease activity.

Options: View larger image (or click on image) Download as PowerPoint

XIST expression in PBMCs correlates with SLE status and disease activit...
RNA flow cytometry was used to measure XIST and Rpl13A expression levels in PBMCs from women with SLE (n = 11) versus healthy women (n = 12). (A and B) Dot plots showing XIST (A) and RPL13A (B) MFI in SLE and control PBMCs. Healthy controls are also shown in Supplemental Figure 3C. (C–E) XIST MFI in B cells (C), T cells (D), and monocytes (E) from patients with SLE and controls. (F) Bar graph showing XIST MFI in SLE patients with a PGA ≥ 1 (n = 7) and a PGA < 1 (n = 4). (G) Scatterplot of XIST MFI versus SLEDAI. Pearson’s correlation coefficient and P value for linear regression shown. (A–E) * indicates P < 0.05, and ** indicates P < 0.01. Error bars indicate 1 standard deviation. (A–F) Expression of XIST or RPL13A compared between patients with SLE and healthy donors (A–E) or disease groups (F) by t test. (G) Correlation tested by simple linear regression.

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts